Related Experiment Videos
Long-term results of tricuspid annuloplasty according to DeVega
1Department of Cardiovascular and Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Insights
DeVega tricuspid annuloplasty combined with mitral valve surgery effectively treats tricuspid regurgitation, improving patient function and symptoms. Long-term results show significant clinical benefit and low complication rates.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Devices
Background:
- Tricuspid regurgitation often coexists with mitral valve disease.
- Surgical management of tricuspid regurgitation in conjunction with mitral valve procedures requires careful consideration.
Purpose of the Study:
- To evaluate the long-term outcomes of the DeVega tricuspid annuloplasty technique.
- To assess the efficacy and safety of combined tricuspid annuloplasty and mitral valve surgery.
Main Methods:
- Analysis of 36 patients who underwent DeVega tricuspid annuloplasty between 1981-1990.
- Concurrent procedures included mitral valve replacement/repair, aortic valve replacement, aortocoronary bypass, and septal defect closure.
- Echocardiography and clinical evaluation for follow-up (6-72 months, mean 36 months).
Main Results:
- Significant tricuspid regurgitation occurred in only 3 patients, with one symptomatic case.
- 72% of patients improved functionally from NYHA Class III/IV to I/II.
- 81% of patients reported subjective improvement in their condition.
Conclusions:
- Simultaneous surgical management of tricuspid regurgitation in patients with mitral valve disease is clinically justified.
- The DeVega annuloplasty technique is an appropriate and effective surgical option for these patients.
Abstract:
The long-term results on 36 patients undergoing tricuspid annuloplasty according to DeVega over the years 1981-1990 were analyzed. All had mitral valve replacement or repair in addition to the above procedure. Moreover, three patients had aortic valve replacement while aortocoronary bypass and interatrial septal defect closure was performed in two cases each. Duration of follow-up ranged between 6 to 72 months (mean 36 months). All patients were examined by echocardiography. Significant tricuspid regurgitation was found in three of the patients operated on, manifest clinical signs of the condition were present in one female patient only. Functional evaluation reassigned 72% of the operated patients from Class III and IV to Class I and II, and apparent subjective improvement was reported by 81% of patients. The analysis showed that indication of patients for simultaneous management of tricuspid regurgitation associated with mitral valve disease is justified, and that the surgical technique employed is appropriate.